Financials & Filings Show all 2022 Q3 Harvard Bioscience Announces Third Quarter 2022 Financial Results Q3 2022 Harvard Bioscience, Inc. Earnings Conference Call Earnings Presentation 807.1 KB Form 10-Q Proxy Statements Filing date View Apr 7, 2022 0001171843-22-002450.pdf 0001171843-22-002450.rtf 0001171843-22-002450.xls View HTML Apr 8, 2021 0001171843-21-002394.pdf 0001171843-21-002394.rtf 0001171843-21-002394.xls View HTML Form 10-K Filing date View Mar 11, 2022 View HTML 0001171843-22-001806.pdf 0001171843-22-001806.rtf 0001171843-22-001806.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Mar 12, 2021 View HTML 0001171843-21-001737.pdf 0001171843-21-001737.rtf 0001171843-21-001737.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-Q There are no SEC filings available. Shareholder Tools Printed Materials Email Alerts RSS Print Share Facebook LinkedIn Twitter RSS
Financials & Filings Show all 2022 Q3 Harvard Bioscience Announces Third Quarter 2022 Financial Results Q3 2022 Harvard Bioscience, Inc. Earnings Conference Call Earnings Presentation 807.1 KB Form 10-Q Proxy Statements Filing date View Apr 7, 2022 0001171843-22-002450.pdf 0001171843-22-002450.rtf 0001171843-22-002450.xls View HTML Apr 8, 2021 0001171843-21-002394.pdf 0001171843-21-002394.rtf 0001171843-21-002394.xls View HTML Form 10-K Filing date View Mar 11, 2022 View HTML 0001171843-22-001806.pdf 0001171843-22-001806.rtf 0001171843-22-001806.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Mar 12, 2021 View HTML 0001171843-21-001737.pdf 0001171843-21-001737.rtf 0001171843-21-001737.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-Q There are no SEC filings available.
